A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy

NCT06211751 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematologic Malignancy

Interventions

DRUG: TQB3909 tablets
DRUG: TQB3702 tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.